Baxter International (NYSE:BAX) Stock Unloaded Rep. Lisa C. McClain

Representative Lisa C. McClain (R-Michigan) recently sold shares of Baxter International Inc. (NYSE:BAX). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Baxter International stock on October 30th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Baxter International Price Performance

Shares of BAX opened at $18.66 on Wednesday. The company has a quick ratio of 1.49, a current ratio of 2.30 and a debt-to-equity ratio of 1.30. Baxter International Inc. has a twelve month low of $17.40 and a twelve month high of $37.74. The stock has a market capitalization of $9.59 billion, a P/E ratio of -62.21, a P/E/G ratio of 0.73 and a beta of 0.57. The company has a 50 day moving average of $21.07 and a 200-day moving average of $25.40.

Baxter International (NYSE:BAX) last released its earnings results on Thursday, October 30th. The medical instruments supplier reported $0.69 earnings per share for the quarter, beating analysts’ consensus estimates of $0.60 by $0.09. Baxter International had a negative net margin of 1.42% and a positive return on equity of 16.96%. The business had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $2.88 billion. During the same quarter last year, the firm earned $0.80 earnings per share. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. Baxter International has set its Q4 2025 guidance at 0.520-0.570 EPS. FY 2025 guidance at 2.350-2.400 EPS. As a group, equities research analysts forecast that Baxter International Inc. will post 2.48 EPS for the current fiscal year.

Baxter International Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Friday, November 28th will be paid a $0.01 dividend. The ex-dividend date is Friday, November 28th. This represents a $0.04 annualized dividend and a yield of 0.2%. Baxter International’s payout ratio is presently -6.06%.

Institutional Trading of Baxter International

A number of institutional investors have recently bought and sold shares of BAX. Teachers Retirement System of The State of Kentucky raised its position in shares of Baxter International by 4.8% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 39,470 shares of the medical instruments supplier’s stock valued at $1,351,000 after buying an additional 1,799 shares in the last quarter. KLP Kapitalforvaltning AS increased its stake in Baxter International by 3.3% during the 1st quarter. KLP Kapitalforvaltning AS now owns 179,976 shares of the medical instruments supplier’s stock worth $6,187,000 after acquiring an additional 5,800 shares during the period. Sound Shore Management Inc. CT lifted its position in shares of Baxter International by 13.7% during the 1st quarter. Sound Shore Management Inc. CT now owns 2,825,902 shares of the medical instruments supplier’s stock valued at $96,731,000 after acquiring an additional 341,321 shares during the period. Arkadios Wealth Advisors bought a new position in shares of Baxter International in the first quarter worth $590,000. Finally, OVERSEA CHINESE BANKING Corp Ltd acquired a new position in Baxter International in the first quarter valued at about $246,000. Institutional investors own 90.19% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on BAX shares. Jefferies Financial Group lowered their target price on Baxter International from $25.00 to $21.00 and set a “hold” rating on the stock in a research report on Thursday, October 30th. Argus cut Baxter International from a “buy” rating to a “hold” rating in a research note on Friday, October 31st. UBS Group cut their price objective on Baxter International from $24.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, October 31st. Wells Fargo & Company lowered their price objective on shares of Baxter International from $33.00 to $24.00 and set an “equal weight” rating on the stock in a research note on Friday, August 1st. Finally, Citigroup cut their target price on shares of Baxter International from $26.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, October 31st. Two analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $23.70.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.